[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.237.51.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
June 6, 2011

Increasing Adolescent Vaccination Coverage: The Challenges That Remain

Author Affiliations

Author Affiliations: Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Arch Pediatr Adolesc Med. 2011;165(6):568-570. doi:10.1001/archpediatrics.2011.65

Between 2005 and 2007, the recommended vaccination schedule for adolescents expanded to include vaccines to protect against pertussis, meningitis (MCV4), and for girls, human papillomavirus (HPV).1-3 The most recent data available from the 2009 National Immunization Survey-Teen show that, while coverage among 13- to 17-year-old adolescents has been increasing for each of these vaccines, it remains suboptimal: 55.6% received pertussis, 53.6% received MCV4, and 26.7% (females only) received all 3 doses of the HPV vaccine series.4 Evidenced-based strategies to increase vaccination coverage among adolescents are needed.

×